Home > Pressrelease > Anti-snoring Treatment Market worth over $8.2bn by 2027
Anti-snoring Treatment Market worth over $8.2bn by 2027
- Published Date: April 22, 2021
Anti-snoring Treatment Market size is set to surpass USD 8.2 billion by 2027, according to a new research report by Global Market Insights Inc.
Increasing adoption of unhealthy lifestyle has contributed to development of several comorbidities along with obesity. As per the Centres for Disease Control and Prevention (CDC), around one in three adults and one in five children suffer from obesity in the U.S. Obese population suffers from several conditions including obstructive sleep apnea (OSA) and snoring. It potentially narrows individual's airway, that can lead to development of OSA. Furthermore, growing consumption of alcohol and tobacco, that is also likely to lead to obesity and snoring problems, will spur the demand for anti-snoring devices in the coming years.
Growing geriatric population base and awareness rate will create robust demand for anti-snoring devices
Rising prevalence of snoring and awareness about snoring disorder treatment options will influence the market growth. Aging, among other risk factors, is a common factor leading to snoring. According to the Sleep Foundation, central sleep apnea is known to impact about nine percent of adults aged above 40 years, especially among men. Thus, with increasing pervasiveness of sleep apnea and snoring, the awareness regarding anti-snoring devices including oral appliances has grown over the coming years. Moreover, growing infrastructure and accessibility to sleep clinics in developed regions of the world will fuel the market expansion during the forecast period.
Cost-effectivity will augment demand for mandible advancement devices (MAD)
Mandible advancement devices (MAD) segment accounted for USD 1 billion in 2020. Mandible advancement devices or mandibular repositioning devices are widely being used to treat snoring. MADs have minimal side effects and are affordable. These devices are available broadly in stores, clinics and over e-commerce platforms, thereby increasing their accessibility and adoption. In addition, growing awareness rate about snoring disorders will boost device acceptance during the forecast timeframe.
Browse key industry insights spread across 100 pages with 67 market data tables & 11 figures & charts from the report, “Anti-snoring Treatment Market Size By Device (Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-commerce), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
Rising demand for better quality healthcare and focus on wellness will drive the retail pharmacy segment
Retail pharmacies segment is expected to witness 8.6% growth rate till 2027 led by high accessibility and availability of wide range of anti-snoring devices. Moreover, technological advancement has increased productivity and provided value-added services to the customers. Thus, the consumer demand is projected to remain high for anti-snoring devices though retail pharmacies due to associated benefits such as accessibility and availability.
Increasing incidence of snoring and obstructive sleep apnea in the European countries will positively impact the demand for anti-snoring devices
Europe anti-snoring treatment market size was over USD 998.9 million in 2020. Increasing burden of sleep apnea and rising number of obese people are driving the demand for anti-snoring treatment alternatives. According to the Health Europe Stats, there were approximately 175 million people in Europe that had obstructive sleep apnea in 2018. Additionally, according to the Health Survey conducted in 2019, in Germany, nearly 13% of the total population were suffering from snoring and about 2,51,344 are the victims of snoring disorder in Germany. Hence, growing prevalence of snoring and sleep apnea will impel the demand for the industry during the forecast timeline.
Eminent players are concentrating on adoption of various growth strategies including product portfolio expansion to strengthen their market position
Few of the prominent companies operating in the market include SomnoMed, Airway Management, Tomed GmBH, ResMed, Pure Sleep Co, and Theravent among others. Firms are emphasizing on product development and launch for expanding their offerings to their customers.